← Back to Search

Behavioral Intervention

Intermittent Hypoxia for Blood Sugar Levels

N/A
Recruiting
Led By Sophie Lalande
Research Sponsored by University of Texas at Austin
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Must not have
Are taking insulin or more than one antihypertensive medication
Have a history of cardiovascular disease or indication of cardiovascular disease such as myocardial infarction, left ventricular hypertrophy, ischemic heart disease (or prior ischemia), stroke, and/or other vascular disease
Timeline
Screening 3 weeks
Treatment Varies
Follow Up collected at min 0, 30, 60, 90 and 120 minutes of the oral glucose tolerance test
Awards & highlights

Summary

"This trial aims to study how intermittent hypoxia affects how the body processes sugar in healthy people, people with prediabetes, and people with type 2 diabetes."

Who is the study for?
This trial is for healthy individuals, those with prediabetes, and patients with type 2 diabetes to study how low oxygen levels affect blood sugar control. Specific eligibility details are not provided.
What is being tested?
The trial investigates the effects of intermittent hypoxia (periods of low oxygen) versus normal oxygen levels on the body's response to a glucose tolerance test.
What are the potential side effects?
Potential side effects are not detailed in the information provided but may include symptoms related to changes in blood oxygen levels.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am taking insulin or more than one blood pressure medication.
Select...
I have a history of heart or blood vessel disease.
Select...
My blood pressure is often above 140/90 mmHg.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~collected at min 0, 30, 60, 90 and 120 minutes of the oral glucose tolerance test
This trial's timeline: 3 weeks for screening, Varies for treatment, and collected at min 0, 30, 60, 90 and 120 minutes of the oral glucose tolerance test for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in plasma glucose levels

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Intermittent hypoxiaExperimental Treatment1 Intervention
The intermittent hypoxia protocol will consist of eight 4-minute hypoxic cycles (arterial oxygen saturation of 80%) interspersed with normoxic cycles (room air) to resaturation.
Group II: Intermittent normoxiaPlacebo Group1 Intervention
The intermittent normoxia protocol will consist of eight 4-minute normoxic cycles (compressed air) interspersed with 1-minute normoxic cycles (room air).
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Intermittent hypoxia
2020
N/A
~150

Find a Location

Who is running the clinical trial?

University of Texas at AustinLead Sponsor
370 Previous Clinical Trials
83,161 Total Patients Enrolled
Sophie LalandePrincipal InvestigatorUT Austin
2 Previous Clinical Trials
71 Total Patients Enrolled
~1 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top